Biomarker Guided Therapy for Heart Failure: The GUIDE-IT study

(56:11)

Accelerating biomarker-guided drug development with Precision For Medicine

(31:38)

Biomarker-guided therapy in CLL

(1:43)

Toxic astrogliosis in MS - precision, biomarker-guided combination therapies

(10:29)

Novel Biomarker-Guided Treatment: PSMA, PAR, HDACs, etc.

(36:44)

Personalized Acute Care Medicine: A Biomarker-Guided Approach by Fred Korley, MD, PhD

(15:50)

Clinical Outcome Biomarker-Guided Therapies in Adult Patients with Tumors of the Nervous Systems

(7:4)

Biomarker-Guided Neoadjuvant Therapy for Bladder Cancer

(1:6:18)

Biomarker-guided treatment of CLL in the chemo-free era

(6:54)

Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in N...

(7:18)

Evaluating neoadjuvant FLOT response and the need for biomarker-guided strategies in GEA

(2:10)

Biomarker-Guided Antibiotic Duration in Sepsis: The ADAPT Sepsis RCT

(3:2)

Developing biomarker-guided treatments for lung cancer

(1:14)

Biomarkers to guide active surveillance

(6:5)

Biomarkers in Heart Failure: How to Guide Clinicians

(50:26)

Panel Discussion: From Comparative Pathogenesis to Biomarker-guided Treatments in Psoriasis \u0026Eczema

(10:3)

Guide to cancer biomarkers

(2:38)

MS-GUIDE: A Biomarker Discovery and Translation Strategy

(10:13)

ACC.12 | Biomarker Guided Heart Failure Management

(32:16)

Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSC...

(6:28)